CS
CANO

Credit Suisse’s Cano Health, Inc. CANO Stock Holding History

Credit Suisse’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,868
Closed -$47.4K – 3197
2023
Q3 		$47.4K Sell
1,868
-113
-6% -$9.29K ﹤0.01% 3118
2023
Q2 		$275K Buy
1,981
+743
+60% +$95.3K ﹤0.01% 3029
2023
Q1 		$113K Sell
1,238
-349
-22% -$47.4K ﹤0.01% 3193
2022
Q4 		$217K Buy
1,587
+53
+3% +$17.9K ﹤0.01% 3156
2022
Q3 		$1.33M Buy
1,534
+398
+35% +$249K ﹤0.01% 2119
2022
Q2 		$497K Sell
1,136
-136
-11% -$70.9K ﹤0.01% 2839
2022
Q1 		$807K Sell
1,272
-1,332
-51% -$840K ﹤0.01% 2677
2021
Q4 		$2.32M Buy
2,604
+1,654
+174% +$1.74M ﹤0.01% 2678
2021
Q3 		$1.21M Buy
+950
New +$1.15M ﹤0.01% 3188

Other funds holding CANO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse's CANO Position: Q4 2023 in Review

Credit Suisse sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 1,868 shares — an estimated $47.4K sold.

Credit Suisse first reported a position in CANO in Q3 2021 and held it in 9 quarters. The position peaked at $2.32M in Q4 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Credit Suisse reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 1,868 Cano Health, Inc. shares in Q4 2023, an estimated $47.4K.
  • Credit Suisse first reported a position in Cano Health, Inc. in Q3 2021 and held it in 9 quarters.
  • Credit Suisse's Cano Health, Inc. position peaked at $2.32M in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.